Most cited papers from Kantonsspital St. Gallen

Kantonsspital St. Gallen

What are the most cited papers from Kantonsspital St. Gallen?

The most cited paper from Kantonsspital St. Gallen is "Definition and classification of cancer cachexia: an international consensus" (Kenneth Fearon, Florian Strasser, Stefan D. Anker et al., 2011), with 5,828 citations. Next come "Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011" (3,932) and "Dose-Response Analysis Using R" (3,885).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 59 papers. Every paper with more than 639 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Definition and classification of cancer cachexia: an international consensus Kenneth Fearon, Florian Strasser, Stefan D. Anker et al. · The Lancet Oncology	5 Feb 2011	5,828
2	Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 Aron Goldhirsch, W. C. Wood, Alan Stuart Coates et al. · Annals of Oncology Open access	28 Jun 2011	3,932
3	Dose-Response Analysis Using R Christian Ritz, Florent Baty, Jens Carl Streibig et al. · PLoS ONE Open access	30 Dec 2015	3,885
4	Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 Aron Goldhirsch et al. · Annals of Oncology Open access	6 Aug 2013	3,776
5	EAU Guidelines on Prostate Cancer Axel Heidenreich, Gunnar Aus, M. Bolla et al. · European Urology Open access	20 Sep 2007	3,150
6	ESPEN guidelines on nutrition in cancer patients Jann Arends et al. · Clinical Nutrition Open access	6 Aug 2016	3,121
7	EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update Josef S Smolen et al. · Annals of the Rheumatic Diseases Open access	22 Jan 2020	2,807
8	Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC Victor Stalin Raj, Huihui Mou, Saskia L. Smits et al. · Nature Open access	Mar 2013	2,153
9	A comprehensive classification of thoracic and lumbar injuries F. Magerl, Max Aebi, S. D. Gertzbein et al. · European Spine Journal	Aug 1994	2,077
10	Global vascular guidelines on the management of chronic limb-threatening ischemia Michael S. Conte et al. · Journal of Vascular Surgery Open access	28 May 2019	1,974
11	EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update Josef S Smolen et al. · Annals of the Rheumatic Diseases Open access	10 Nov 2022	1,921
12	Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015 Alan Stuart Coates et al. · Annals of Oncology Open access	4 May 2015	1,865
13	Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy Nicholas David James et al. · New England Journal of Medicine Open access	3 Jun 2017	1,806
14	ESPEN practical guideline: Clinical Nutrition in cancer Maurizio Muscaritoli et al. · Clinical Nutrition Open access	18 Mar 2021	1,532
15	EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Treatment of Clinically Localised Disease Axel Heidenreich, Joaquim Bellmunt, M. Bolla et al. · European Urology	29 Oct 2010	1,498
16	Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy Alison J. Rodger et al. · JAMA Open access	12 Jul 2016	1,453
17	Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry J. Mazieres et al. · Annals of Oncology Open access	15 May 2019	1,390
18	Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009 Aron Goldhirsch, James N. Ingle, Richard D. Gelber et al. · Annals of Oncology Open access	17 Jun 2009	1,381
19	ESPEN expert group recommendations for action against cancer-related malnutrition Jann Arends, Vickie Elaine Baracos, Hartmut Bertz et al. · Clinical Nutrition Open access	23 Jun 2017	1,326
20	Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial Christopher Parker et al. · The Lancet Open access	21 Oct 2018	1,289
21	Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss in Patients With Morbid Obesity Ralph Peterli, Bettina Karin Wölnerhanssen, Thomas T. A. Peters et al. · JAMA Open access	16 Jan 2018	1,273
22	De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 Giuseppe Curigliano et al. · Annals of Oncology Open access	11 Jun 2017	1,263
23	The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria Torsten Zuberbier et al. · Allergy Open access	18 Sep 2021	1,253
24	Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Bernard J. Escudier, Camillo Porta, Manuela Schmidinger et al. · Annals of Oncology Open access	18 Feb 2019	1,180
25	Meeting Highlights: International Expert Consensus on the Primary Therapy of Early Breast Cancer 2005 Aron Goldhirsch, John H. Glick, Richard D. Gelber et al. · Annals of Oncology Open access	7 Sep 2005	1,133
26	Mapping the human genetic architecture of COVID-19 COVID-19 Host Genetics Initiative et al. · Nature Open access3,896 authors	8 Jul 2021	1,130
27	EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) – revised report of an EFNS task force The EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis, Peter Munch Andersen, Sharon Abrahams et al. · European Journal of Neurology	14 Sep 2011	1,119
28	Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab Stefan Diem, Sabine P. Schmid, Mirjam Krapf et al. · Lung Cancer	24 Jul 2017	1,046
29	A systematic review of physicians' survival predictions in terminally ill cancer patients Paul A. Glare, Kiran Virik, Mark Jones et al. · BMJ ReviewOpen access	24 Jul 2003	1,044
30	Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study Alison J. Rodger et al. · The Lancet Open access189 authors	2 May 2019	1,029
31	Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest Josef Dankiewicz et al. · New England Journal of Medicine Open access	16 Jun 2021	1,017
32	Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition) Andrea Cossarizza et al. · European Journal of Immunology Open access436 authors	Oct 2019	1,014
33	Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer Philippe Rougier, Eric Van Cutsem, Emilio Bajetta et al. · The Lancet	Oct 1998	995
34	A Cre-inducible diphtheria toxin receptor mediates cell lineage ablation after toxin administration Thorsten Buch, Frank L. Heppner, Christine Tertilt et al. · Nature Methods	20 May 2005	968
35	Systemic Treatment of Early Breast Cancer by Hormonal, Cytotoxic, or Immune Therapy:133 Randomised Trials involoving 31 000 Recurrences and 24 000 Deaths Among 75 000 Women (Summary) Early Breast Cancer Trialists’ Collaborative Group, R. Peto · Recent results in cancer research/Recent Results in Cancer Research Book chapter	1993	965
36	Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007 Aron Goldhirsch, W. C. Wood, Richard D. Gelber et al. · Annals of Oncology Open access	Jul 2007	947
37	Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study Bruno Ledergerber, Matthias Egger, Milos Opravil et al. · The Lancet	Mar 1999	932
38	2′-O methylation of the viral mRNA cap evades host restriction by IFIT family members Stéphane Daffis, Kristy J. Szretter, Jill M. Schriewer et al. · Nature Open access	16 Nov 2010	927
39	Individualised nutritional support in medical inpatients at nutritional risk: a randomised clinical trial Philipp Schüetz et al. · The Lancet Open access	25 Apr 2019	905
40	Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1 Myron S. Cohen, Irving Hoffman, Rachel A. Royce et al. · The Lancet	Jun 1997	882
41	The “Forgotten Joint” as the Ultimate Goal in Joint Arthroplasty Henrik Behrend, Karlmeinrad Giesinger, Johannes Maria Giesinger et al. · The Journal of Arthroplasty	17 Oct 2011	868
42	Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021 Harold J. Burstein et al. · Annals of Oncology Open access	6 Jul 2021	842
43	Ribose 2′-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5 Roland Züst, Luisa Cervantes‐Barragán, Matthias Habjan et al. · Nature Immunology Open access	9 Jan 2011	819
44	Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4 Zdeněk Škrott et al. · Nature Open access	Dec 2017	815
45	Diagnostic Criteria for the Classification of Cancer-Associated Weight Loss Lisa Warsinger Martin, Pierre Sénesse, Ioannis Gioulbasanis et al. · Journal of Clinical Oncology	24 Nov 2014	804
46	Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance Andreas Limmer, Jutta Ohl, Christian Kurts et al. · Nature Medicine Open access	Dec 2000	759
47	Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer Olivia Pagani et al. · New England Journal of Medicine Open access	Jun 2014	756
48	EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update Bernhard Hellmich et al. · Annals of the Rheumatic Diseases Open access	16 Mar 2023	748
49	Sarcopenia: A Time for Action. An SCWD Position Paper Jürgen Martin Bauer et al. · Journal of Cachexia Sarcopenia and Muscle Open access	15 Sep 2019	745
50	Genome-wide Analyses Identify KIF5A as a Novel ALS Gene Aude Nicolas et al. · Neuron Open access540 authors	Mar 2018	728

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.